These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38275711)

  • 1. The Molecular Mechanism Underlying the Therapeutic Effect of Dihydromyricetin on Type 2 Diabetes Mellitus Based on Network Pharmacology, Molecular Docking, and Transcriptomics.
    Wen X; Lv C; Zhou R; Wang Y; Zhou X; Qin S
    Foods; 2024 Jan; 13(2):. PubMed ID: 38275711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate improves glucose and lipid metabolism in db/db mice by regulating the metabolic profile and the MAPK/PI3K/Akt signalling pathway.
    Chen L; Wang J; Ren Y; Ma Y; Liu J; Jiang H; Liu C
    Phytomedicine; 2024 Apr; 126():155382. PubMed ID: 38382280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus.
    Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H
    Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
    Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
    Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on Dihydromyricetin Improving Aflatoxin Induced Liver Injury Based on Network Pharmacology and Molecular Docking.
    Zhu X; Liu S; Pei H; Chen W; Zong Y; Zhao Y; Li J; Du R; He Z
    Toxics; 2023 Sep; 11(9):. PubMed ID: 37755770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
    Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of dihydromyricetin on cognitive dysfunction in type 2 diabetes mice].
    Zhu ZM; Yang JH; Yang SS; He JQ; Zhang KF; Feng SD; Ling HY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):323-328. PubMed ID: 29926637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic mechanism of Yuye decoction on type 2 diabetes mellitus based on network pharmacology and experimental verification.
    Guo F; Yao L; Zhang W; Chen P; Hao R; Huang X; Jiang J; Wu S
    J Ethnopharmacol; 2023 May; 308():116222. PubMed ID: 36828194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.
    Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB
    J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the mechanism of Jingshen Xiaoke decoction in treating T2DM mice based on network pharmacology and molecular docking.
    Mao Y; Pan S; Song Y; Wang W; Li N; Feng B; Zhang J
    Technol Health Care; 2024; 32(1):163-179. PubMed ID: 37092194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes, biological functions, and pathways of empagliflozin by network pharmacology and its significance in the treatment of type 2 diabetes mellitus.
    Zhong H; Duan BH; Du FM; Wang WM; Qiao H
    Ann Transl Med; 2023 Jan; 11(2):123. PubMed ID: 36819540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydromyricetin improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain-derived neurotrophic factor-mediated neuroprotection in mice.
    Ling H; Zhu Z; Yang J; He J; Yang S; Wu D; Feng S; Liao D
    Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):298-306. PubMed ID: 29425256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential effects and mechanisms of hispidulin in the treatment of diabetic retinopathy based on network pharmacology.
    Chen Y; Sun J; Zhang Z; Liu X; Wang Q; Yu Y
    BMC Complement Med Ther; 2022 May; 22(1):141. PubMed ID: 35590353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating network pharmacology and non-targeted metabolomics to explore the common mechanism of Coptis Categorized Formula improving T2DM zebrafish.
    He T; Wang M; Kong J; Wang Q; Tian Y; Li C; Wang Q; Liu C; Huang J
    J Ethnopharmacol; 2022 Feb; 284():114784. PubMed ID: 34718103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antidepressant effect and molecular mechanism of notoginsenoside R_1 based on network pharmacology and animal experiments].
    Li Y; Zhang YY; Wu D; Qi KM; Lu W; Wei YC
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5599-5609. PubMed ID: 36471978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
    Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of Zhongfeng Xingnao Decoction in improving microcirculatory disorders in cerebral hemorrhage based on network pharmacology and molecular docking techniques].
    Zhong XQ; Hu DF; Wang Y; Ning ZQ; Deng MZ
    Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6115-6127. PubMed ID: 38114219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.